Balyasny Asset Management »

Cogent Biosciences shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $375k 44k 8.43
2023-09-30 $1.2M 126k 9.75
2023-03-31 $216k 20k 10.79
2022-09-30 $16M 1.0M 14.92
2022-06-30 $9.9M 1.1M 9.02

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Cogent Biosciences

Point72 Asset Management
Kynam Capital Management
BlackRock
Commodore Capital
BlackRock
TCG Crossover Management
Fairmount Funds Management
VR Adviser
Vanguard Group
Paradigm Biocapital Advisors
Redmile Group
State Street Corporation
Deerfield Management Company
Geode Capital Management
Sofinnova Ventures

View all funds holding Cogent Biosciences